{"symbol": "OPHT", "companyName": "Ophthotech Corporation", "exchange": "Nasdaq Global Select", "industry": "Biotechnology", "website": "http://www.ophthotechinc.com", "description": "Ophthotech Corporation, a biopharmaceutical company, develops novel therapeutics to treat diseases of the back of the eye. Its principal product candidate is called as Fovista.", "CEO": "Glenn P. Sblendorio", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}